ProtoKinetix Inc. Email Format
Biotechnology ResearchOhio, United States2-10 Employees
ProtoKinetix Inc. is a biotechnology research and development company founded in 2002 and based in Marietta, Ohio. The company concentrates on cell survival solutions, anchored by its patented anti-aging glycopeptide, AAGP, a naturally occurring molecule described as capable of supporting cell survival and regeneration. It envisions applications in ophthalmology, dermatology, transplant support, and biomanufacturing, reflecting its aim to influence a range of medical fields. AAGP has undergone laboratory testing in Europe and North America, with results described as safe, stable, and capable of protecting and regenerating cells. Recent developments include programs to develop AAGP for Dry Eye Disease and to screen PKX-001 for cardiometabolic disorders. ProtoKinetix operates with a small research-focused team in the biotechnology sector as it pursues foundational work with potential clinical implications.